1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Hungary Pharmaceuticals and Healthcare Report Q1 2016

Hungary Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 81 pages

Includes 3 FREE quarterly updates

BMI View: Hungary's pharmaceutical market represents a moderate but reliable commercial prospectwithin Central and Eastern Europe. The government plays a key role in the provision of medical services asdemonstrated by its recent ban on parallel exports of medicines and the decentralisation of primary care.We nevertheless expect the private sector to become more involved over the medium term.

Headline Expenditure Projections

-Pharmaceuticals: HUF648.10bn (USD2.79bn) in 2014 to HUF660.80bn (USD2.36bn) in 2015; +2.0%in local currency terms and -15.3% in US dollar terms.

-Healthcare: HUF2.38trn (USD10.22bn) in 2014 to HUF2.42trn (USD8.65bn) in 2015; +1.9% in localcurrency terms and -15.3% in US dollar terms.

Table Of Contents

Hungary Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Hungary 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2011-2019) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019) 21
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2011-2019) 23
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 2011-2019) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2013-2019) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2013-2019) 28
Industry Risk Reward Index 29
Central And Eastern Europe Risk/Reward Index - Q1 2016 29
Hungary Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Intellectual Property Issues 40
Pricing Regime 41
Table: OEP Reimbursement Changes, September 2014 43
Reimbursement Regime 43
Market Overview 46
Healthcare System 47
Table: Healthcare Resources (Hungary 2009-2014) 48
Table: Healthcare Personnel (Hungary 2009-2014) 49
Table: Healthcare Activity (Hungary 2009-2014) 49
Healthcare Funding 49
Research and Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 55
Research Based Industry 55
Table: Multinational Market Activity 57
Generic Drugmakers 58
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 60
Company Profile 62
Egis Pharmaceuticals (Servier) 62
Gedeon Richter 65
Demographic Forecast 70
Table: Population Headline Indicators (Hungary 1990-2025) 71
Table: Key Population Ratios (Hungary 1990-2025) 71
Table: Urban/Rural Population and Life Expectancy (Hungary 1990-2025) 72
Table: Population By Age Group (Hungary 1990-2025) 72
Table: Population By Age Group % (Hungary 1990-2025) 73
Glossary 75
Methodology 77
Pharmaceutical Expenditure Forecast Model 77
Healthcare Expenditure Forecast Model 77
Notes On Methodology 78
Risk/Reward Index Methodology 79
Index Overview 80
Table: Pharmaceutical Risk/Reward Index Indicators 80
Indicator Weightings 81q

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.